143 related articles for article (PubMed ID: 30573190)
1. Re-evaluating resection of primary pancreatic neuroendocrine tumors.
Pommier RF
Surgery; 2019 Mar; 165(3):557-558. PubMed ID: 30573190
[No Abstract] [Full Text] [Related]
2. Should we lose hope in adjuvant therapy for neuroendocrine tumors?-In response to: Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit.
Lamberti G; Manuzzi L; Maggio I; Campana D
J Surg Oncol; 2020 Sep; 122(3):570-571. PubMed ID: 32519754
[No Abstract] [Full Text] [Related]
3. Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors-There is hope, but more data are needed.
Barrett JR; Abbott DE
J Surg Oncol; 2020 Sep; 122(3):572. PubMed ID: 32419171
[No Abstract] [Full Text] [Related]
4. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors.
Frilling A; Clift AK
Ann Surg Oncol; 2017 Nov; 24(12):3466-3468. PubMed ID: 28815440
[No Abstract] [Full Text] [Related]
5. [Gastroenteropancreatic neuroendocrine tumors. Editorial].
Díaz Pérez JA
Endocrinol Nutr; 2009 Apr; 56 Suppl 2():1. PubMed ID: 19627762
[No Abstract] [Full Text] [Related]
6. [Clinicopathological characterization of gastro-entero- pancreatic neuroendocrine tumors].
Borka K
Magy Onkol; 2018 Jul; 62(2):90-97. PubMed ID: 30027936
[TBL] [Abstract][Full Text] [Related]
7. Small Bowel Neuroendocrine Tumors: Big Advances in the Land of Small Tumors.
Singh S; Chan DL
J Oncol Pract; 2018 Aug; 14(8):485-486. PubMed ID: 30096275
[No Abstract] [Full Text] [Related]
8. [Primary tumor diagnostics of metastatic neuroendocrine tumors].
Dralle H
Chirurg; 2018 Jan; 89(1):63. PubMed ID: 29264627
[No Abstract] [Full Text] [Related]
9. Progress in the Evaluation and Treatment of Small Bowel Neuroendocrine Tumors.
Mulvey CK; Bergsland EK
J Oncol Pract; 2018 Aug; 14(8):487-489. PubMed ID: 30096272
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors.
Massironi S; Rossi RE
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):858-859. PubMed ID: 30145647
[No Abstract] [Full Text] [Related]
11. Classification of neuroendocrine tumors.
Klöppel G
Verh Dtsch Ges Pathol; 1997; 81():111-7. PubMed ID: 9474861
[TBL] [Abstract][Full Text] [Related]
12. Comment on "Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment".
Chen QC; Zheng QW; Luo S; Zhao H
Ann Surg; 2021 Dec; 274(6):e758-e759. PubMed ID: 33065634
[No Abstract] [Full Text] [Related]
13. Comment on "Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment".
Wang WQ; Gao HL; Zhang WH; Liu L; Yu XJ
Ann Surg; 2021 Dec; 274(6):e743-e744. PubMed ID: 32694442
[No Abstract] [Full Text] [Related]
14. Letter to the editor: Multidisciplinary management of pancreatic neuroendocrine tumors--the importance of an aggressive surgical approach.
Labori KJ; Haugvik SP; Line PD
Scand J Gastroenterol; 2016 Mar; 51(3):383-4. PubMed ID: 26458136
[No Abstract] [Full Text] [Related]
15. Reassessing the grade of gastroenteropancreatic neuroendocrine neoplasms.
Klimstra DS
Endocrine; 2016 Jul; 53(1):4-6. PubMed ID: 27150611
[No Abstract] [Full Text] [Related]
16. ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.
Garcia-Carbonero R; Sorbye H; Baudin E; Raymond E; Wiedenmann B; Niederle B; Sedlackova E; Toumpanakis C; Anlauf M; Cwikla JB; Caplin M; O'Toole D; Perren A;
Neuroendocrinology; 2016; 103(2):186-94. PubMed ID: 26731334
[No Abstract] [Full Text] [Related]
17. Management of gastro-entero-pancreatic neuroendocrine tumours (GEP NET): an introduction.
Van Hootegem P; Borbath I; Verslype C
Acta Gastroenterol Belg; 2009; 72(1):27-8. PubMed ID: 19402367
[No Abstract] [Full Text] [Related]
18. A short report of 50 patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN).
Laenkholm IT; Langer SW; Andreassen M; Holmager P; Kjaer A; Klose M; Federspiel BH; Hansen CP; Knigge U
Acta Oncol; 2021 Jun; 60(6):808-812. PubMed ID: 33779475
[No Abstract] [Full Text] [Related]
19. Emerging treatment options for patients with gastroenteropancreatic neuroendocrine tumors.
Phan AT
Clin Adv Hematol Oncol; 2017 Apr; 15 Suppl 4(4):10-14. PubMed ID: 28654024
[No Abstract] [Full Text] [Related]
20. Refining the management of patients with gastroenteropancreatic neuroendocrine tumors.
Iyer R
Clin Adv Hematol Oncol; 2017 Apr; 15 Suppl 4(4):3-10. PubMed ID: 28654023
[No Abstract] [Full Text] [Related]
[Next] [New Search]
